Mesenchymal stem cell vs. chondrocyte implantation for repair of chondral knee defects .
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Matrix-induced autologous mesenchymal stem cell implantation versus matrix-induced autologous chondrocyte implantation in the treatment of chondral defects of the knee: a 2-year randomized study
Arch Orthop Trauma Surg. 2015 Feb;135(2):251-63.14 patients with isolated single full-thickness femoral condylar chondral defects of the knee (>2 cm-squared in area) qualifying for cartilage repair surgery were randomized to receive either matrix-induced autologous mesenchymal stem cell implantation (m-AMI), or matrix-induced autologous chondrocyte implantation (m-ACI). The purpose of this study was to evaluate and compare the objective and subjective functional, radiological and clinical outcomes from the use of both grafts. Strength testing, knee motion, Knee Injury and Osteoarthritis Outcome Scores. Tegner scores, pain and MOCART scoring were assessed preoperatively, and 6, 12 and 24 months postoperatively. The findings of this trial indicate that the both grafts successfully repaired chondral defects.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
